Fennec Pharmaceuticals Inc. ($FENC)
Filing Information
| Accession Number | 0001468316-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 5, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
46,716
Total Value
$154,801.40
P&L
+inf% (+$38,122.56)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common shares | โ | Dec 31, 2025 | Grant/Award | 5,208 | $0.00 | $0.00 | 82,734 | Direct | โ | View Details | |
Director | Common shares | โ | Jan 2, 2026 | Exercise/Conversion | 15,598 | $2.45 | $38,215.10 | 98,332 | Direct | โ | View Details | |
Director | Common shares | โ | Jan 2, 2026 | Sale | 10,312 | $7.60 | $78,371.20 | 88,020 | Direct | โ | View Details | |
Director | Stock Options | Derivative | Jan 2, 2026 | Exercise/Conversion | 15,598 | $2.45 | $38,215.10 | 1,618,586 | Direct | โ | View Details |